Helix 8 of the angiotensin-II type 1A receptor interacts with phosphatidylinositol phosphates and modulates membrane insertion

被引:13
|
作者
Hirst, Daniel J. [1 ]
Lee, Tzong-Hsien [1 ]
Pattenden, Leonard K. [1 ]
Thomas, Walter G. [2 ]
Aguilar, Marie-Isabel [1 ]
机构
[1] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3800, Australia
[2] Univ Queensland, Sch Biomed Sci, St Lucia, Qld 4072, Australia
来源
SCIENTIFIC REPORTS | 2015年 / 5卷
基金
英国医学研究理事会; 澳大利亚研究理事会;
关键词
AT(1A) CARBOXYL-TERMINUS; LIPOPOLYSACCHARIDE INTERACTIONS; ANTIMICROBIAL PEPTIDES; CRYSTAL-STRUCTURE; PROXIMAL REGION; LIPIDS; PROTEINS; DOMAIN;
D O I
10.1038/srep09972
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The carboxyl-terminus of the type 1 angiotensin II receptor (AT(1A)) regulates receptor activation/deactivation and the amphipathic Helix 8 within the carboxyl-terminus is a high affinity interaction motif for plasma membrane lipids. We have used dual polarisation interferometry (DPI) to examine the role of phosphatidylinositdes in the specific recognition of Helix 8 in the AT(1A) receptor. A synthetic peptide corresponding to Leu(305) to Lys(325) (Helix 8 AT(1A)) discriminated between PIPs and different charges on lipid membranes. Peptide binding to PtdIns(4) P-containing bilayers caused a dramatic change in the birefringence (a measure of membrane order) of the bilayer. Kinetic modelling showed that PtdIns(4) P is held above the bilayer until the mass of bound peptide reaches a threshold, after which the peptides insert further into the bilayer. This suggests that Helix 8 can respond to the presence of PI(4) P by withdrawing from the bilayer, resulting in a functional conformational change in the receptor.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] ONTOGENY OF THE 2 ANGIOTENSIN-II TYPE-1 RECEPTOR SUBTYPES IN RATS
    SHANMUGAM, S
    CORVOL, P
    GASC, JM
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1994, 267 (06): : E828 - E836
  • [42] INTERNALIZATION OF THE TYPE-I ANGIOTENSIN-II RECEPTOR (AT1) AND ANGIOTENSIN-II FUNCTION IN THE RAT ADRENAL ZONA GLOMERULOSA CELL
    VINSON, GP
    HO, MM
    PUDDEFOOT, JR
    TEJA, R
    BARKER, S
    KAPAS, S
    HINSON, JP
    ENDOCRINE RESEARCH, 1995, 21 (1-2) : 211 - 217
  • [43] CHROMOSOMAL LOCALIZATION OF ANGIOTENSIN-II TYPE-1 RECEPTOR ISOFORMS IN THE RAT
    LEWIS, JL
    SERIKAWA, T
    WARNOCK, DG
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 194 (02) : 677 - 682
  • [44] INTERNALIZATION OF THE TYPE-I ANGIOTENSIN-II RECEPTOR (AT1) AND ANGIOTENSIN-II FUNCTION IN THE RAT ADRENAL ZONA GLOMERULOSA CELL
    VINSON, GP
    HO, MM
    PUDDEFOOT, JR
    TEJA, R
    BARKER, S
    JOURNAL OF ENDOCRINOLOGY, 1994, 141 (02) : R5 - R9
  • [45] DIFFERENTIAL REGULATION OF TYPE 1A ANGIOTENSIN-II RECEPTOR GENE-EXPRESSION IN KIDNEY AND ADRENAL-GLAND BY SODIUM LOADING
    WANG, DH
    DU, Y
    HYPERTENSION, 1995, 26 (03) : 566 - 566
  • [46] Angiotensin II type 1a receptor mediates adriamycin-induced cardiotoxicity
    Hara, F
    Morita, T
    Tatebe, J
    Yamashina, S
    Yoshino, G
    Yamazaki, J
    CIRCULATION, 2004, 110 (17) : 202 - 202
  • [47] Deletion of the Angiotensin II Type 1a Receptor Prevents Atherosclerotic Plaque Rupture
    Aono, Jun
    Suzuki, Jun
    Ogimoto, Akiyoshi
    Okayama, Hideki
    Iwai, Masaru
    Horiuchi, Masatsugu
    Higaki, Jitsuo
    CIRCULATION, 2010, 122 (21)
  • [48] Angiotensin II type 1a receptor mediates doxorubicin-induced cardiomyopathy
    Toko, H
    Oka, T
    Zou, YZ
    Sakamoto, M
    Mizukami, M
    Sano, M
    Yamamoto, R
    Sugaya, T
    Komuro, I
    HYPERTENSION RESEARCH, 2002, 25 (04) : 597 - 603
  • [49] INFLUENCE OF TISSUE FREEZING ON THE BINDING OF I-125 SARCOSINE(1), ISOLEUCINE(8) ANGIOTENSIN-II TO ANGIOTENSIN-II RECEPTOR SUBTYPES IN THE RAT
    LU, XY
    ZHANG, W
    GROVE, KL
    SPETH, RC
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 1995, 33 (02) : 83 - 90
  • [50] CHROMOSOMAL LOCALIZATION OF TYPE-1A AND TYPE-1B ANGIOTENSIN-II RECEPTOR IN THE RAT
    LEWIS, JL
    SERIKAWA, T
    WARNOCK, DG
    HYPERTENSION, 1992, 20 (03) : 411 - 411